Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 179
Filtrar
1.
J Neurol Neurosurg Psychiatry ; 80(7): 794-7, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19237386

RESUMO

OBJECTIVE: To determine how intraoperative microelectrode recordings (MER) and intraoperative lead placement acutely influence tremor, rigidity, and bradykinesia. Secondarily, to evaluate whether the longevity of the MER and lead placement effects were influenced by target location (subthalamic nucleus (STN) or globus pallidus interna (GPi)). BACKGROUND: Currently most groups who perform deep brain stimulation (DBS) for Parkinson disease (PD) use MER, as well as macrostimulation (test stimulation), to refine DBS lead position. Following MER and/or test stimulation, however, there may be a resultant "collision/implantation" or "microlesion" effect, thought to result from disruption of cells and/or fibres within the penetrated region. These effects have not been carefully quantified. METHODS: 47 consecutive patients with PD undergoing unilateral DBS for PD (STN or GPi DBS) were evaluated. Motor function was measured at six time points with a modified motor Unified Parkinson Disease Rating Scale (UPDRS): (1) preoperatively, (2) immediately after MER, (3) immediately after lead implantation/collision, (4) 4 months following surgery-off medications, on DBS (12 h medication washout), (5) 6 months postoperatively-off medication and off DBS (12 h washout) and (6) 6 months-on medication and off DBS (12 h washout). RESULTS: Significant improvements in motor scores (p<0.05) (tremor, rigidity, bradykinesia) were observed as a result of MER and lead placement. The improvements were similar in magnitude to what was observed at 4 and 6 months post-DBS following programming and medication optimisation. When washed out (medications and DBS) for 12 h, UPDRS motor scores were still improved compared with preoperative testing. There was a larger improvement in STN compared with GPi following MER (p<0.05) and a trend for significance following lead placement (p<0.08) but long term outcome was similar. CONCLUSION: This study demonstrated significant acute intraoperative penetration effects resulting from MER and lead placement/collision in PD. Clinicians rating patients in the operating suite should be aware of these effects, and should consider pre- and post-lead placement rating scales prior to activating DBS. The collision/implantation effects were greater intraoperatively with STN compared with GPi, and with greater disease duration there was a larger effect.


Assuntos
Estimulação Encefálica Profunda/métodos , Globo Pálido/cirurgia , Movimento , Doença de Parkinson/cirurgia , Núcleo Subtalâmico/cirurgia , Idoso , Antiparkinsonianos/uso terapêutico , Terapia Combinada , Eletrodos Implantados/estatística & dados numéricos , Feminino , Seguimentos , Globo Pálido/fisiopatologia , Humanos , Hipocinesia/tratamento farmacológico , Hipocinesia/fisiopatologia , Hipocinesia/cirurgia , Levodopa/uso terapêutico , Masculino , Microeletrodos/estatística & dados numéricos , Pessoa de Meia-Idade , Movimento/efeitos dos fármacos , Rigidez Muscular/tratamento farmacológico , Rigidez Muscular/fisiopatologia , Rigidez Muscular/cirurgia , Procedimentos Neurocirúrgicos/métodos , Doença de Parkinson/diagnóstico , Doença de Parkinson/tratamento farmacológico , Doença de Parkinson/fisiopatologia , Núcleo Subtalâmico/fisiopatologia , Resultado do Tratamento , Tremor/tratamento farmacológico , Tremor/fisiopatologia , Tremor/cirurgia
3.
Bull. W.H.O. (Print) ; 79(12): 1159-1167, 2001.
Artigo em Inglês | WHO IRIS | ID: who-268481
4.
Health Econ ; 8(3): 233-43, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10348418

RESUMO

In recent years, most health care markets in the United States (US) have experienced rapid penetration by health maintenance organizations (HMOs) and preferred provider organizations (PPOs). During this same period, the US has also experienced slowing health care costs. Using a national database, we demonstrate that HMOs and PPOs have significantly restrained cost growth among hospitals located in competitive hospital markets, but not so in the case of hospitals located in relatively concentrated markets. In relative terms, we estimate that HMOs have contained cost growth more effectively than PPOs.


Assuntos
Competição Econômica/tendências , Sistemas Pré-Pagos de Saúde/economia , Custos Hospitalares/tendências , Organizações de Prestadores Preferenciais/economia , Setor de Assistência à Saúde/tendências , Sistemas Pré-Pagos de Saúde/estatística & dados numéricos , Humanos , Medicare/economia , Modelos Econométricos , Organizações de Prestadores Preferenciais/estatística & dados numéricos , Análise de Regressão , Estados Unidos
6.
Heart ; 80(1): 19-22, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9764053

RESUMO

BACKGROUND: Unstable angina is a heterogeneous clinical syndrome. The diverse clinical presentations of unstable angina may reflect different pathogenic mechanisms within the plaque. OBJECTIVE: To investigate the cellular constituents of culprit coronary atheromatous plaques in patients with stable angina pectoris and patients with diverse clinical presentations of unstable angina. METHODS: 48 patients who underwent coronary atherectomy for management of ischaemic heart disease: 23 had stable angina and 25 had unstable angina. Of the latter, 11 patients were classified as Braunwald's IIB and 14 as Braunwald's IIIB unstable angina. The presence of thrombus, cholesterol clefts, and smooth muscle cell proliferation was assessed in atherectomy samples using standard histological techniques. Monoclonal antibodies were used to identify smooth muscle cells and macrophages within atherosclerotic plaque fragments. RESULTS: Fresh thrombus was more frequently found in patients with Braunwald's IIIB unstable angina (64%) than in patients with stable angina (22%) or IIB unstable angina (27%) (p < 0.0006). A pattern of smooth muscle cell proliferation ("accelerated progression pattern") was observed which was also associated with coronary thrombus. This pattern was present in 30% of patients with stable angina, 64% of patients with IIIB unstable angina, and in all patients (100%) with IIB unstable angina. Atherosclerotic plaques with thrombus, cholesterol clefts, and macrophages were more common in patients with unstable angina than in stable angina patients. CONCLUSION: The presence of a specific smooth muscle cell proliferation (accelerated progression) pattern in patients with unstable angina, particularly in those with Braunwald's IIB unstable angina, suggests that episodic plaque disruption and subsequent healing may be an important mechanism underlying angina symptoms in these patients.


Assuntos
Angina Instável/patologia , Vasos Coronários/patologia , Adulto , Angina Pectoris/patologia , Angina Pectoris/cirurgia , Angina Instável/cirurgia , Aterectomia Coronária , Divisão Celular , Colesterol/análise , Trombose Coronária/patologia , Vasos Coronários/química , Progressão da Doença , Feminino , Humanos , Macrófagos/patologia , Masculino , Pessoa de Meia-Idade , Músculo Liso Vascular/patologia
7.
West J Med ; 169(2): 118-21, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9735698
11.
J Int Assoc Physicians AIDS Care ; 4(5): 42-3, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-11365188

RESUMO

AIDS: Although a preventive vaccine is essential for controlling the HIV/AIDS epidemic and AIDS vaccine candidates exist, field trials of AIDS vaccine candidates are still not underway. Reasons for field trials of HIV vaccines not being underway include: ethical issues regarding how such trials would be conducted, fear that trial failure would make successive trials impossible to conduct, and controversy among the scientific community that the current crop of vaccines will effectively protect against HIV infection. Explanations for why none of these arguments are realistic reasons for delays in testing are provided. The ethical and human rights issues underlying the failure to proceed with field trials are also explored.^ieng


Assuntos
Vacinas contra a AIDS , Infecções por HIV/prevenção & controle , Vacinas contra a AIDS/efeitos adversos , Vacinas contra a AIDS/uso terapêutico , Ética Médica , Infecções por HIV/imunologia , Direitos Humanos , Humanos
12.
Health Aff (Millwood) ; 16(4): 223-32, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9248168

RESUMO

This DataWatch examines national trends in the provision of uncompensated hospital care. It shows that rapid growth from 1983-1986 was followed by modest growth through 1990, a time during which managed care was becoming established in some regions. There was then another spurt in uncompensated care from 1991-1993, a period that corresponds to sizable increases in disproportionate-share payments. Uncompensated care growth again slowed through 1995. The increase in uncompensated care levels after 1988 appears not to have kept pace with growth in hospital expenses or the number of uninsured. However, the trend data do not suggest a large-scale reduction of effort.


Assuntos
Pesquisas sobre Atenção à Saúde , Custos Hospitalares/tendências , Indigência Médica/tendências , Cuidados de Saúde não Remunerados/tendências , American Hospital Association , Controle de Custos/tendências , Previsões , Custos Hospitalares/estatística & dados numéricos , Hospitais de Ensino/economia , Hospitais de Ensino/estatística & dados numéricos , Hospitais Urbanos/economia , Hospitais Urbanos/estatística & dados numéricos , Humanos , Programas de Assistência Gerenciada/economia , Programas de Assistência Gerenciada/tendências , Indigência Médica/estatística & dados numéricos , Seguridade Social/economia , Cuidados de Saúde não Remunerados/estatística & dados numéricos , Estados Unidos
13.
Hastings Cent Rep ; 27(3): 6-13, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9219018

RESUMO

There is more to modern health than new scientific discoveries, the development of new technologies, or emerging or re-emerging diseases. World events and experiences, such as the AIDS epidemic and the humanitarian emergencies in Bosnia and Rwanda, have made this evident by creating new relationships among medicine, public health, ethics, and human rights. Each domain has seeped into the other, making allies of public health and human rights, pressing the need for an ethics of public health, and revealing the rights-related responsibilities of physicians and other health care workers.


Assuntos
Ética Médica , Direitos Humanos , Internacionalidade , Papel Profissional , Saúde Pública , Infecções por HIV/prevenção & controle , Humanos , Comunicação Interdisciplinar , Objetivos Organizacionais , Médicos , Responsabilidade Social , Fatores Socioeconômicos
15.
Prosthet Orthot Int ; 21(3): 183-6, 1997 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9453090

RESUMO

The purpose of this study was to review the clinical utility of static weight bearing (SWB) and maximal self-selected ambulatory velocity as objective quantifiable measures in an outpatient lower limb prosthetic clinic. Seventy-three (n = 73) consecutive trans-tibial (TTA) and trans-femoral amputees (TFA) attending an outpatient prosthetic clinic were studied. Prosthetic weight bearing was measured on a bathroom scale (mass in kg), normalised to body mass then expressed as a percentage and labelled static weight bearing (SWB). Maximum safe self-selected ambulatory velocity over a 10 metre level walkway (m/s) was measured with a stopwatch. The SWB mean for the TTA group was 94.93% range 77-100%) and 88.36% for the TFA group (range 43-100%). The mean ambulatory velocity was 1.70 m/s (range 0.07-5.75) for the TTA group and 0.78 m/s (range 0.10-1.54) for the TFA group. A statistically significant relationship (p < 0.05) was found between SWB and ambulatory velocity in trans-tibial and trans-femoral amputees in this study. A ceiling effect was noted in the trans-tibial group with 42% achieving 100% SWB through their prosthetic limb so it was concluded that ambulatory velocity was the more sensitive measure in established trans-tibial prosthetic limb users. SWB may be the more appropriate quantifiable measure for use in established trans-femoral prosthesis users. Prosthetic training programmes would benefit from the objective measurement of SWB. Once optimal SWB was achieved, ambulatory velocity would be the more sensitive measure of prosthetic use.


Assuntos
Amputados/reabilitação , Membros Artificiais , Fêmur/fisiopatologia , Marcha , Resistência Física/fisiologia , Tíbia/fisiopatologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Instituições de Assistência Ambulatorial , Fenômenos Biomecânicos , Criança , Feminino , Humanos , Articulação do Joelho/fisiopatologia , Perna (Membro)/cirurgia , Masculino , Pessoa de Meia-Idade , Desenho de Prótese , Ajuste de Prótese , Tecnologia Assistiva , Caminhada , Suporte de Carga
17.
J Clin Anesth ; 8(8): 623-6, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8982887

RESUMO

STUDY OBJECTIVE: To determine if the addition of alfentanil to propofol is more effective than propofol alone to provide adequate conditions for placement of a retrobulbar block prior to cataract surgery. DESIGN: Randomized, double-blinded study. SETTING: Outpatients at a university hospital. PATIENTS: 40 adult ASA physical status I, II, and III outpatients scheduled for elective cataract surgery. INTERVENTIONS: Patients were randomly assigned to receive one of four drug combinations prior to the placement of a retrobulbar block: Group 1, propofol alone; Group 2, alfentanil 5 micrograms/kg plus propofol; Group 3, alfentanil 10 micrograms/kg plus propofol; Group 4, alfentanil 15 micrograms/kg plus propofol. All patients were preoxygenated by face mask for two minutes prior to drug administration. The quality of conditions for block placement were determined by: (1) assessing the amount of movement by the patients while the block needle was in place, (2) cooperativeness of the patients during the operation, (3) hemodynamic side effects, (4) incidence and severity of respiratory depression, (5) incidence of nausea and vomiting, (6) recall of placement of the block, and (7) time to discharge from the hospital. MEASUREMENTS AND MAIN RESULTS: The addition of alfentanil to propofol for sedation prior to placement of the retrobulbar block resulted in a dose-dependent reduction in movement by the patients. However, the highest dose of alfentanil (15 micrograms/kg) resulted in the greatest frequency (40% of the patients in this group) of respiratory depression (SpO2 < 90%). All patients were cooperative during the operation and responsive to verbal command within 5 minutes of placement of the block. In addition, all of the patients denied being nauseated, having vomited, or recalling block placement in the recovery room or the next day. CONCLUSIONS: The combination of alfentanil and propofol may be used to sedate patients in order to limit movement and provide a cooperative, alert patient with stable hemodynamics and limited respiratory depression during placement of retrobulbar block prior to ophthalmic surgery. However, excessive dosage of these drugs may result in hazardous respiratory depression in this patient population.


Assuntos
Alfentanil/administração & dosagem , Anestésicos Intravenosos/administração & dosagem , Extração de Catarata , Sedação Consciente , Olho , Hipnóticos e Sedativos/administração & dosagem , Bloqueio Nervoso , Propofol/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , Procedimentos Cirúrgicos Ambulatórios , Comportamento Cooperativo , Relação Dose-Resposta a Droga , Método Duplo-Cego , Procedimentos Cirúrgicos Eletivos , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Incidência , Tempo de Internação , Masculino , Rememoração Mental/efeitos dos fármacos , Pessoa de Meia-Idade , Movimento , Náusea/induzido quimicamente , Agulhas , Bloqueio Nervoso/instrumentação , Respiração/efeitos dos fármacos , Vômito/induzido quimicamente
18.
Hosp Pract (1995) ; 31(10): 63-6, 69, 72-3 passim, 1996 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-8859208

RESUMO

The decline of new HIV infections among subgroups in industrialized countries has created a false sense of security; globally, about 13,000 new infections occur each day. In developing countries, limited health care spending bars all but a privileged few from access to new treatment. In the absence of an effective vaccine and intensified prevention, spread of the virus will continue unabated.


Assuntos
Síndrome da Imunodeficiência Adquirida/epidemiologia , Países em Desenvolvimento , Saúde Global , Soroprevalência de HIV , Síndrome da Imunodeficiência Adquirida/transmissão , Adolescente , Adulto , Criança , Feminino , Humanos , Masculino , Prevalência , Fatores Sexuais
19.
Circulation ; 94(5): 928-31, 1996 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-8790027

RESUMO

BACKGROUND: The microanatomic features of the atherosclerotic plaque at risk of disruption include a large lipid core, a high macrophage content, and a thin cap. The relation between lipid core size, plaque size, and cap thickness either with each other or with the degree of stenosis has yet to be evaluated in human coronary arteries. METHODS AND RESULTS: Atherosclerotic coronary plaques (n = 160) were obtained from 31 subjects who died suddenly of ischemic heart disease. In coronary arteries perfused with formol saline at a pressure of 100 mm Hg, stenosis was measured by comparison of the minimal lumen size at the site of a plaque with that of the lumen in an adjacent normal segment of artery. Plaque size, the size of the lipid core, and the thickness of the cap were measured in histological sections. Lipid core size ranged from 0% to 82% of overall plaque size. Seventeen percent of plaques had a core size of > 50%. Linear regression showed no relation of core size to stenosis (r = .21). Absolute plaque size bore no relation to core size (r = .14). Minimal cap thickness was not related to core size (r = .06). Ten percent of plaques predicted to be angiographically invisible had cores of > 50%. CONCLUSIONS: Two major determinants of plaque vulnerability, core size and cap thickness, are not statistically related. Neither of these two factors that confer vulnerability are related to absolute plaque size or to the degree of stenosis.


Assuntos
Doença da Artéria Coronariana/patologia , Doença das Coronárias/patologia , Idoso , Angiografia Coronária , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
20.
BMJ ; 312(7036): 924-5, 1996 Apr 13.
Artigo em Inglês | MEDLINE | ID: mdl-8616294
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...